Healthcare Stocks Based on Data Mining: Returns up to 22.1% in 7 Days

Healthcare Stocks

This Healthcare Stocks Package is designed for investors and analysts who need predictions of the best shares within the Healthcare Sector. It includes 20 stocks with bullish and bearish signals and indicates the best healthcare stocks to buy and sell:

  • Top 10 HealthCare stocks for the long position
  • Top 10 HealthCare stocks for the short position

Healthcare
Package Name: Healthcare
Recommended Positions: Long
Forecast Length: 7 Days (2/3/2020 – 2/10/2020)
I Know First Average: 7.67%
Healthcare Stocks
Healthcare Stocks chart

The algorithm correctly predicted 9 out 10 of the suggested trades in the Healthcare Package for this 7 Days forecast. The greatest return came from ESPR at 22.1%. The suggested trades for RVNC and ICUI also had notable 7 Days yields of 20.34% and 15.42%, respectively. The package had an overall average return of 7.67%, providing investors with a 3.75% premium over the S&P 500’s return of 3.92% during the period.

Esperion Therapeutics, Inc., incorporated on January 22, 2008, is a lipid management company. The Company is a late-stage pharmaceutical company focused on developing and commercializing once-daily, oral therapies for the treatment of patients with elevated low-density lipoprotein cholesterol (LDL-C). With a targeted mechanism of action, bempedoic acid, the Company’s lead product candidate, is an orally available, once-daily adenosine triphosphate (ATP)-citrate lyase (ACL) inhibitor that reduces cholesterol biosynthesis and lowers elevated levels of LDL-C by up-regulating the LDL receptor, but with reduced potential for muscle-related side effects. In addition to bempedoic acid as monotherapy, the Company is also developing bempedoic acid in a fixed dose combination with ezetimibe, an approved, non-statin, oral, LDL-C lowering therapy.

As of December 31, 2016, the Company had completed Phase II clinical studies of bempedoic acid. As of December 31, 2016, the Company was engaged in conducting its global Phase III clinical development program for bempedoic acid.

Algorithmic traders utilize these daily forecasts by the I Know First market prediction system as a tool to enhance portfolio performance, verify their own analysis and act on market opportunities faster. This forecast was sent to current I Know First subscribers.

How to interpret this diagram

Algorithmic Stock Forecast: The table on the left is a stock forecast produced by I Know First’s algorithm. Each day, subscribers receive forecasts for six different time horizons. Note that the top 10 stocks in the 1-month forecast may be different than those in the 1-year forecast. In the included table, only the relevant stocks have been included. The boxes are arranged according to their respective signal and predictability values (see below for detailed definitions). A green box represents a positive forecast, suggesting a long position, while a red represents a negative forecast, suggesting a short position.

Please note-for trading decisions use the most recent forecast. Get today’s forecast and Top stock picks.